Etoposide: discovery and medicinal chemistry

Current Medicinal Chemistry
Philippe MeresseEmmanuel Bertounesque

Abstract

Etoposide is an antitumor agent currently in clinical use for the treatment of small cell lung cancer, testicular cancer and lymphomas. Since the introduction of etoposide in 1971, its mechanism of action and potent antineoplastic activity has served as the impetus for intensive research activities in chemistry and biology. This drug acts by stabilizing a normally transient DNA-topoisomerase II complex, thus increasing the concentration of double-stranded DNA breaks. This phenomenon triggers mutagenic and cell death pathways. The function of topoisomerase II is understood in some detail, as is the mechanism of inhibition of etoposide at a molecular level. Etoposide has shortcomings of limited neoplastic activity against several solid tumors such as non-small cell lung cancer, cross-resistance to MDR tumor cell lines and low bioavailability. The design and synthesis of etoposide analogs is an activity of fundamental interest to the field of cancer chemotherapy. In the first part, this article is a survey of the discovery of etoposide, the DNA topoisomerase II structure and mechanism, and the models for drug-enzyme interaction. The last part is concerned with the search for new etoposide analogs based upon an empirical design.

Citations

Dec 27, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M Gordaliza
Jul 25, 2012·ACS Combinatorial Science·Anatoliy M ShestopalovVictor V Semenov
May 23, 2012·Journal of Medicinal Chemistry·Andrés AbadArturo San Feliciano
Oct 4, 2006·Nature Reviews. Drug Discovery·Peter ImmingAchim Meyer
Feb 24, 2006·Organic & Biomolecular Chemistry·Syed G A MoinuddinNorman G Lewis
Mar 8, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Hsi-Kung KuoDan-Ning Hu
Jun 3, 2006·Doklady Biological Sciences : Proceedings of the Academy of Sciences of the USSR, Biological Sciences Sections·A G PaleevaA A Shtil
Sep 16, 2008·Molecular Cancer Therapeutics·Mitsunori OkabeMichael M Gottesman
Nov 11, 2011·International Journal of Nanomedicine·Elaine R TavaresRaul C Maranhão
Oct 12, 2010·Journal of Nucleic Acids·Donna M Gordon, Janine Hertzog Santos
Sep 23, 2014·European Journal of Medicinal Chemistry·Wang ChenYuemao Shen
Jun 2, 2015·Expert Opinion on Therapeutic Patents·Ahmed KamalSyed Riyaz
Aug 30, 2008·Expert Opinion on Drug Metabolism & Toxicology·Jason M HatfieldPhilip M Potter
Nov 6, 2007·FEBS Letters·Christina N MorkRemco A Spanjaard
Jun 4, 2011·European Journal of Medicinal Chemistry·Alexandre NovoaYves Chapleur
Apr 26, 2011·Experimental Cell Research·Ana TamarkinEtta Livneh
May 3, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Tiecheng ZhangWeisan Pan
Aug 3, 2010·Micron : the International Research and Review Journal for Microscopy·Sara SalucciElisabetta Falcieri
Jul 5, 2008·The American Journal of Pathology·Jenilyn J VirreyFlorence M Hofman
Jan 31, 2006·Journal of Neurochemistry·Sokhon PinMichael M Wang
Nov 11, 2010·Veterinary and Comparative Oncology·W M FitzPatrickB E Kitchell
Aug 26, 2006·The International Journal of Biochemistry & Cell Biology·Santiago Rello-VaronaAngeles Villanueva
Jul 19, 2005·Current Opinion in Biotechnology·Laurence B Davin, Norman G Lewis
Feb 1, 2013·Pharmaceutical Biology·Estela GuerreroArturo San Feliciano
Jul 8, 2015·Journal of Cancer Prevention·Young Ho Seo
Jul 14, 2016·Nucleic Acids Research·Kevin Z L WuCorrado Santocanale
Aug 25, 2016·Frontiers in Genetics·Rania Nakad, Björn Schumacher
Jul 16, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nasser Hanna, Lawrence H Einhorn
Feb 9, 2008·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Luca ZoiaBruno Rindone
Dec 5, 2017·Frontiers in Molecular Biosciences·Anthony J Berdis
Sep 3, 2011·Archiv der Pharmazie·Wang ChengniuZhu Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
K R Hande
Current Medicinal Chemistry. Anti-cancer Agents
E L Baldwin, N Osheroff
Cancer Letters
Alessandra Montecucco, Giuseppe Biamonti
© 2021 Meta ULC. All rights reserved